CORELLI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 10.877
EU - Europa 9.738
AS - Asia 1.734
AF - Africa 49
SA - Sud America 30
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.459
Nazione #
US - Stati Uniti d'America 10.840
GB - Regno Unito 2.767
IE - Irlanda 1.623
CN - Cina 1.230
IT - Italia 1.044
UA - Ucraina 1.029
SE - Svezia 817
FR - Francia 687
RU - Federazione Russa 666
DE - Germania 611
SG - Singapore 310
FI - Finlandia 297
TR - Turchia 74
CI - Costa d'Avorio 34
ES - Italia 33
BE - Belgio 28
CA - Canada 28
CZ - Repubblica Ceca 26
AU - Australia 23
IN - India 21
JP - Giappone 20
VN - Vietnam 17
NL - Olanda 16
CL - Cile 15
RO - Romania 14
PL - Polonia 13
BR - Brasile 11
AT - Austria 9
HK - Hong Kong 8
KR - Corea 7
PK - Pakistan 7
CH - Svizzera 6
DK - Danimarca 6
EE - Estonia 6
EG - Egitto 6
SI - Slovenia 6
ZA - Sudafrica 6
BG - Bulgaria 4
EU - Europa 4
GR - Grecia 4
HU - Ungheria 4
IR - Iran 4
SA - Arabia Saudita 4
TH - Thailandia 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
IM - Isola di Man 3
LK - Sri Lanka 3
LT - Lituania 3
MX - Messico 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AR - Argentina 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
DZ - Algeria 1
GE - Georgia 1
GH - Ghana 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 22.459
Città #
Southend 2.587
Dublin 1.620
Fairfield 1.503
Menlo Park 1.465
Jacksonville 846
Chandler 812
Woodbridge 717
Ashburn 671
Wilmington 642
Houston 545
Seattle 500
Cambridge 494
Ann Arbor 345
Siena 332
Beijing 306
Princeton 296
Nanjing 289
Singapore 208
Boardman 148
Nanchang 124
Helsinki 121
San Diego 95
San Mateo 92
Fremont 85
Moscow 72
Shenyang 66
New York 64
Florence 61
Izmir 61
Tianjin 54
Hebei 53
Düsseldorf 44
Shanghai 43
Dearborn 41
Milan 41
London 40
Norwalk 40
Rome 40
Venezia 40
Changsha 36
Abidjan 34
Jiaxing 31
Kunming 30
Lancaster 29
Brussels 26
Munich 24
Redwood City 24
Hangzhou 22
Málaga 22
Anguillara Sabazia 20
Guangzhou 20
Jinan 19
Los Angeles 19
San Francisco 19
Ningbo 18
Zhengzhou 17
Brno 14
Naples 14
Changchun 12
Chicago 12
Dong Ket 12
Santa Clara 12
Washington 12
Melbourne 11
Frankfurt am Main 10
Mestre 10
Philadelphia 10
Rende 10
Taizhou 10
Tokyo 10
Bari 9
Mogliano 9
Urlati 9
Vienna 9
Bonndorf 8
Candiolo 8
Cardiff 8
Kilburn 8
Lanzhou 8
Saint Petersburg 8
Toronto 8
Aligarh 7
Hefei 7
Montréal 7
Tappahannock 7
Galatone 6
Haikou 6
Indiana 6
Latina 6
Paris 6
Shenzhen 6
Sydney 6
Tallinn 6
Certaldo 5
Columbus 5
Copenhagen 5
Edinburgh 5
Hong Kong 5
Livorno 5
Madrid 5
Totale 16.375
Nome #
Ligandi TRPV1 351
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 283
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease 224
Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach 208
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: An effective scaffold for the design of either CB1 and CB2 receptor ligands 204
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility 202
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: Involvement of the GABAB and cannabinoid CB1 receptors 191
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury 187
null 186
Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA B receptor 180
New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains 173
Simplified Analogues of Immucillin-G Retain Potent Human Purine Nucleoside Phosphorylase Inhibitory Activity 172
Synthesis of an original oxygenated taxuspine X analogue: a versatile non-natural natural product with remarkable P-gp modulating activity 171
Antifungal agents. 10. New derivatives of 1-[(Aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-Candida activity and Quantitative Structure-Analysis Relationship studies 171
Screen of unfocused libraries identified compounds with direct or synergistic antibacterial activity 169
Dihydro-alkylthio-benzyl-oxopyrimidines as Inhibitors of Reverse Transcriptase: Synthesis and Rationalization of the Biological Data on Both Wild-Type Enzyme and Relevant Clinical Mutants 168
Computational studies of competitive inhibitors of nitric oxide synthase (NOS) enzymes: towards the development of powerful and isoform-selective inhibitors 166
Synthesis, 1 structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof 163
Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy 163
Synthesis, Cannabinoid Receptor Affinity, and Molecular Modeling Studies of Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides 156
Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor 156
Anxiety-like behaviors at the end of the nocturnal period in sP rats with a “history” of unpredictable, limited access to alcohol. 155
Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model 154
NUOVA TERAPIA PER IL TRATTAMENTO DELL'IPERURICEMIA NELLA SINDROME DI LESCH-NYHAN 154
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 6. Synthesis and Pharmacological Evaluation of 7-Substituted 4-Quinolone-3-carboxamide Derivatives as High Affinity Ligands for Cannabinoid Receptors 152
Synthesis and biological evaluation of New N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands 151
Rapid combinatorial access to a library of 1,5-disubstituted-3-indole-N-alkylacetamides as CB2 receptor ligands 151
Microwave-enhanced Sonogashira coupling reaction of substituted pyrimidinones and pyrimidine nucleosides 150
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 1. Synthesis and Structure-Activity Relationship of a Class of Human Immunodeficiency Virus type 1 Integrase Inhibitors 149
Synthetic bioactive olivetol-related amides: the influence of the phenolic group in cannabinoid receptor activity 149
Chiral Azole Derivatives, 3. Synthesis of the Enantiomers of the Potent Aromatase Inhibitor 1-[2-Benzofuranyl(4-chlorophenyl)methyl]-1H-imidazole 148
Synthesis of reactive cytidine derivatives as building blocks for cross-linking oligonucleotides 147
Synthesis and Interaction with Copper(II) Cations of Cyano- and Aminoresorcin[4]arenes 146
Combinatorial chemistry as a tool for targeting different stages of the replicative HIV-1 cycle 146
Solid phase synthesis of 5,6-disubstituted pyrimidinone and pyrimidindione derivatives 146
Synthesis, molecular modeling studies, and pharmacological activity of selective A1 receptor antagonists 146
Parallel solution phase synthesis of 4-dialkylamino-2-methylsulfonyl-6-vinylpyrimidines 145
Solid-phase synthesis (SPS) of substituted uracils via Oxone® cleavage methodology 145
Activation of the GABAB receptor prevents nicotine-induced locomotor stimulation in mice 144
A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitors 144
Design, Synthesis, and Pharmacological Characterization of Indole-3-ylacetamides, Indole-3-yloxoacetamides, and Indole-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 144
Inhibition of alcohol self-administration by positive allosteric modulators of the GABA(B) receptor in rats: lack of tolerance and potentiation of baclofen 144
Regioselective functionalization of quinolin-4(1H)-ones via sequential palladium-catalyzed reactions 143
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with antinociceptive activity in vivo 143
Towards new methodologies for the synthesis of biologically interesting 6-substituted pyrimidines and 4(3H)-pyrimidinones 143
Pyrrolobenzodiazepines and related systems. 2. Synthesis and biological properties of isonoraptazepine derivatives 142
Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies 141
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 4. Identification of New Potent and Selective Ligands for the Cannabinoid Type 2 Receptor with Diverse Substitution Patterns and Antihyperalgesic Effects in Mice 140
A Novel Route to Calix[4]arenes. 2. Solution- and Solid-State Structural Analyses and Molecular Modeling Studies 139
An improved synthesis of solid-supported reagents (SSRs) for selective acylation of amines by microwave irradiation 139
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 3. Synthesis, Structure-Affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-Quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands 135
Polycondensed heterocycles. V. Synthesis of 5H,11H-Pyrrolo[2,1-c][1,4]benzothiazepine 135
A genetic-function-approximation-based QSAR model for the affinity of arylpiperazines toward a1 adrenoceptors 135
Reduction by the positive allosteric modulator of the GABAB receptor, GS39783, of alcohol self-administration in Sardinian alcohol-preferring rats exposed to the “sipper” procedure 134
Novel Substituted Aminoalkylguanidines as Potential Antihyperglycemic and Food Intake-Reducing Agents 134
Probing the substrate specificity for lipases. A CoMFA approach for predicting the hydrolysis rates of 2-arylpropionic esters catalyzed by Candida rugosa lipase 134
Probing the substrate specificity for lipases. II. Kinetic and Modeling Studies on the Molecular Recognition of 2-Arylpropionic Esters by Candida rugosa and Rhizomucor miehei Lipases 134
Antifungal Agents. 11.N-Substituted Derivatives of 1-[(Aryl)(4-aryl-1H-pyrrol-3yl)methyl]-1H-imidazole: Synthesis, Anti-Candida Activity, and QSAR Studies 133
Solution-phase parallel synthesis of S-DABO analogues 133
Reducing effect of saikosaponin A, an active ingredient of Bupleurum falcatum, on alcohol self-administration in rats: Possible involvement of the GABAB receptor 133
In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists 132
Fibroblast growth factors and their inhibitors 132
6-Vinyl pyrimidine and pyrimidinone derivatives and the use thereof 132
Solid Phase Synthesis of 2,6-Disubstituted-4(3H)-pyrimidinones Targeting HIV-1 Reverse Transcriptase 131
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile. 131
New solid-supported reagents (SSRs) for selective acylation of amines 130
Stereoselective synthesis of α-aryl-2-benzofuranmethanamines and α-aryl-1H-indole-2-methanamines through palladium-mediated annulation of chiral α-arylpropargylamines 130
A new linker for anchoring/masking primary amines on solid support 130
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist 130
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol (2-AG) Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 (CB1) Receptor 129
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 2. Synthesis and Structure-Activity Relationship of Potent and Selective Cannabinoid-2 Receptor Agonists Endowed with Analgesic Activity in Vivo 129
Rational design and synthesis of homochiral azole antifungal agents 128
Synthesis and biological evaluation of conformationally restricted analogs of tolmetin and ketorolac 128
Three-Dimensional Quantitative Structure-Selectivity Relationships (3D-QSSR) Analysis Guided Rational Design of a Highly Selective Ligand for the Cannabinoid Receptor 2 126
Exploring the Synthesis of Masked Phosphoramido 6-Vinylcytidine Derivatives as Building Blocks for Cross-Linking Oligonucleotides 126
A combinatorial approach for the solid phase synthesis of 5,6-disubstituted pyrimidinones and pyrimidine derivatives 126
Efficient synthesis of iminoctadine, a potent antifungal agent and polyamine oxidase inhibitor (PAO) 126
The tetramerization of 2,4-dimethoxycinnamates. A novel route to calixarenes 126
Synthesis of pyrazolo[1,5-a]pyrimidine ring as a possible bioisosteric replacement of the 5-(1H-pyrrol-1-yl)pyrazole scaffold 125
The 4-Quinolone-3-carboxylic Acid Motif as a Multivalent Scaffold in Medicinal Chemistry 124
A pharmacophore modeling approach to design new taxol® mimics: towards the synthesis of potential anticancer and MDR-reversing agent 123
Total Synthesis of δ-Sanshool and Analogues Thereof 122
3D QSAR studies of the interaction between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones 121
The bioisosteric concept applied to cannabinoid ligands 121
Cyclic Dipeptides - A Stereocontrolled Synthesis of (2s,3r,6r) and (2r,3r,6r)-6-tert-butoxycarbonylamino-3-methoxycarbonyl-2-methyl-5-oxope Rhydro-1,4-thiazepine 121
Practical synthesis of novel purine analogues as Hsp90 inhibitors. 120
Microwave-assisted ethylene-alkyne cross-metathesis: synthesis of chiral 2-(N-1-acetyl-1-arylmethyl)-1,3-butadienes 119
Stereoselective synthesis of advanced intermediates en route to Taxuspine U and X: a study of macrocyclization via ring closing metathesis to highly constrained twelve-membered rings 119
Studies toward Taxuspine X, a potent Multidrug - Resistance Reversing Agent, via ring closing metathesis strategy 119
6-Substituted-4(3H)-pyrimidinones. A family of antiviral agents possessing a broad spectrum of activities 118
Microwave-assisted synthesis and biological evaluation of novel uracil derivatives inhibiting human thymidine phosphorylase 117
Molecular modeling as a powerful technique for understanding small-large molecules interactions 116
Parallel Solution-Phase and Microwave-Assisted Synthesis of New S-DABO Derivatives Endowed with Subnanomolar Anti-HIV-1 Activity 116
Synthesis, biological evaluation and pharmacophore generation of uracil, 4(3H)-pyrimidinone, and uridine derivatives as potent and selective inhibitors of parainfluenza 1 (Sendai) virus 115
Enantioselective synthesis of 1-aryl-2-propenylamines: a new approach to a stereoselective synthesis of the Taxol® side chain. 114
Preparation of pyrimidine and pyrimidinone derivatives and their use for the treatment of HIV infections 114
Microwave-assisted C-5 iodination of substituted pyrimidinones and pyrimidine nucleosides 114
Polycondensed heterocycles. VII. A convenient synthesis of pyrrolo[1,2-a]quinoxaline derivatives by intramolecular aromatic nucleophilic displacement 114
Molecular modeling of azole antifungal agents active against Candida albicans .1. A comparative molecular field analysis study 114
Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors 113
Totale 14.545
Categoria #
all - tutte 72.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.587


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.519 0 0 0 0 282 300 301 516 332 365 139 284
2020/20213.298 176 325 45 344 136 397 191 486 408 316 296 178
2021/20222.268 173 335 147 217 59 71 134 81 85 263 207 496
2022/20233.384 225 225 468 488 327 713 71 277 350 67 106 67
2023/20242.407 126 41 168 143 89 585 851 73 13 42 38 238
2024/20251.233 95 293 460 281 104 0 0 0 0 0 0 0
Totale 22.667